The Danish Association of the Pharmaceutical Industry (LIF) warns: medicines will come later to Europe and Denmark

Sweden’s regions broaden use of tripartite negotiations

Reimbursement can change even when the medicines do not – KELA revise reimbursement status for severe mental health disorders

NICE sets a dedicated fertility pathway for endometriosis

Lif CEO Sofia Wallström urges focus on timely access in pharma inquiry

TLV updates government on US pricing policy monitoring

Lif chair re-elected amid focus on alignment

CHMP backs five new medicines in March 2026

Danish Medicines Council declines vamorolone for Duchenne

Sykehusinnkjøp switches procurement platform to Ivalua